Comprehensive overview of COVID-19 clinical trials.

Document Type

Article

Publication Date

5-1-2020

Keywords

JGM, Asia, Western, Betacoronavirus, Clinical Studies as Topic, Coronavirus Infections, Female, Humans, Male, Pandemics, Pneumonia, Viral

JAX Source

J Pak Med Assoc 2020 May; 70(Suppl 3):S158-S161

Volume

70(Suppl 3)

Issue

5

First Page

158

Last Page

158

ISSN

0030-9982

PMID

32515404

DOI

https://doi.org/10.5455/jpma.37

Abstract

Here, we present an overview of the clinical trials that are currently being conducted or have concluded to date on COVID-19 globally. A comprehensive search was conducted to present 16 trial registries from around the world. Collectively, there are 1,528 trials reported for COVID-19 to date. Out of them, 50 studies included paediatric age group from day 0 to less than or equal to 18 years of age. A few 18 studies involve only females and 20 only males. There are 2 trials currently underway in Bangladesh, 4 in Pakistan and 13 in India. Overall, 940 trials are related to medicines and/or interventions. They include standard of care for any viral illness, antivirals, anti-inflammatory and immune altering medications. Two out of 10 vaccine trials are novel vaccines. It is knowledgeable and resourceful to reach out to the concerned sponsor if a physician thinks his patient can benefit from the trials in the region.

Link to Full Text

Share

COinS